SQZ’s Point-of-Care (POC) Manufacturing Platform Shows Promising Results with Ability to Produce Cell Therapies at Scale in Under 10 Hours WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: ...
REDWOOD CITY, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced ...
Carrabassett Valley, Maine – The opportunities for digital manufacturing are huge and could transform the way manufacturing industries operate. In the U.S. over 95% of the nation’s 300,000 ...
REDWOOD CITY, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc., a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, presented data at ...
Six presentations highlight innovations designed to shorten TIL manufacturing, new nonclinical data on LYL119, new technologies and clinical trials in progress SOUTH SAN FRANCISCO, Calif., Oct. 31, ...
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ) announced today that the company’s first generation, integrated point-of-care (POC) cell therapy manufacturing system demonstrated ...
SALISBURY — For the first Rowan Chamber’s Power in Partnership of the season, Josh Ward, the National Association of Manufactures’ regional public affairs director, advocated for manufacturing on ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Elon Musk's electric-vehicle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback